News
First assessment of individual brain heterogeneity in mental disorders
The analysis of brain involvement at an individual level has shown that there is a great heterogeneity in the affected regions in individuals with the same clinical diagnosis. In contrast, alterations in neural circuits and networks involving different regions are common among various mental disorders and could therefore become useful as diagnostic markers.
A new heart failure program can reduce hospitalizations and deaths at 90 and 180 days after discharge
According to the study carried out by the IDIBELL research group on cardiovascular diseases (BIOHEART), this program not only could reduce hospital admissions and deaths of patients 30 days after discharge – as it was already proven – but also at 90 and 180 days.
A study concludes that territorial integrated care for people with heart failure reduces the impact of socioeconomic inequality
The Bellvitge Hospital, Primary Care and IDIBELL have analyzed the cases of more than 77,500 heart failure patients in Catalonia between 2015 and 2019.
Imaging biomarker may help to better understand and treat progressive multiple sclerosis
A research work led by neuroradiologists and neurologists from IDIBELL, the Bellvitge University Hospital, and the Institute of Diagnostic Imaging identified a new magnetic resonance biomarker. This biomarker would make it possible to accurately detect the focus of chronic brain inflammation, associated with the progressive form of multiple sclerosis.
First clinical trial of a treatment that attacks lung cancer and brain metastasis at the same time
In a phase 2 clinical trial, researchers have observed that this combination allows to carry out global treatment from the beginning, manages to keep metastases stable for 7
IDIBELL participates in EU-funded ONCODIR project to improve colorectal cancer prevention
Led by the Centre for Research and Technology Hellas (CERTH), the project includes 27 complementary partners from different research domains. This initiative integrates cutting-edge research methodologies powered by artificial intelligence to deliver personalized, evidence-based approaches for preventing this type of cancer.
A meta-analysis by IDIBELL and Bellvitge Hospital examines the use of beta-lactam antibiotics in febrile neutropenia
The results of five studies have been reviewed, two of them randomized clinical trials, with a total of 691 episodes of febrile neutropenia. The effects of the use of beta-lactam antibiotics in intermittent infusions have been compared with prolonged infusions.
New research will look for risk indicators of harmful internet use among adolescents
Dr. Josep Manuel Menchon, group leader at IDIBELL and head of the Psychiatry Service at Bellvitge University Hospital, participates in a pioneering study led by the University of Hertfordshire to address and reduce the risks of harmful Internet use among adolescents.
Maria Eulàlia Juvé and Jordi Adamuz participate in the publication of a nursing mentoring book
The article by Juvé and Adamuz highlights the importance of knowledge of nursing tools and strategies (ATIC and ARES) to improve patient outcomes and the work environment.